Kaya Holdings (KAYS) Cost of Revenue (2012 - 2025)
Kaya Holdings (KAYS) recorded quarterly Cost of Revenue of $38.0 in Q3 2025, down 99.44% quarter-over-quarter from $6735.0 in Q2 2025, and down 86.03% on a YoY basis from $272.0 in Q3 2024.
Kaya Holdings (KAYS) Cost of Revenue (2012 - 2025) Analysis & Trends
Kaya Holdings' Cost of Revenue history runs 14 years deep, the most recent figure standing at $38.0 for Q3 2025.
- In Q3 2025, Cost of Revenue fell 86.03% year-over-year to $38.0; the TTM figure through Sep 2025 stood at $5565.0 (down 84.8% YoY), while the FY2024 annual figure was $7500.0, down 90.78% from the prior year.
- Cost of Revenue was $38.0 for Q3 2025 at Kaya Holdings, down from $6735.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $86729.0 in Q2 2021 to a low of -$6178.0 in Q4 2024.
- Historically, Cost of Revenue has averaged $33612.7 across 5 years, with a median of $22515.5 in 2023.
- The sharpest annual moves came in 2021 and 2024: Cost of Revenue surged 55.08% in 2021, then plunged 126.93% in 2024.
- A 5-year view of Cost of Revenue shows it stood at $54545.0 in 2021, then decreased by 21.65% to $42738.0 in 2022, then sank by 46.32% to $22943.0 in 2023, then slumped by 126.93% to -$6178.0 in 2024, then soared by 100.62% to $38.0 in 2025.
- The last three Cost of Revenue figures came in at $38.0 (Q3 2025), $6735.0 (Q2 2025), and $4970.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | 38.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 38.00 |
| Sep 30, 2025 | 38.00 |
| Jun 30, 2025 | 6,735.00 |
| Jun 30, 2025 | 6,735.00 |
| Mar 31, 2025 | 4,970.00 |
| Mar 31, 2025 | 4,970.00 |
| Dec 31, 2024 | -6,178.00 |
| Dec 31, 2024 | -6,178.00 |
| Sep 30, 2024 | 272.00 |
| Sep 30, 2024 | 272.00 |
| Mar 31, 2024 | 13,406.00 |
| Mar 31, 2024 | 13,406.00 |
| Dec 31, 2023 | 22,943.00 |
| Dec 31, 2023 | 22,943.00 |
| Sep 30, 2023 | 22,088.00 |
| Sep 30, 2023 | 22,088.00 |
| Jun 30, 2023 | 19,717.00 |
| Jun 30, 2023 | 19,717.00 |
| Mar 31, 2023 | 16,597.00 |
| Mar 31, 2023 | 16,597.00 |